Je Openclaw Bezpečnost Vaccine bezpečný?
Openclaw Bezpečnost Vaccine — Nerq Trust Score 56.6/100 (Stupeň D). Skóre založeno na 5 independent trust signals.
Openclaw Bezpečnost Vaccine je software tool se skóre důvěryhodnosti Nerq 56.6/100 (D), based on 5 nezávislých datových dimenzích. Bezpečnost: 0/100. Údržba: 1/100. Popularita: 0/100. Data pocházejí z více veřejných zdrojů včetně registrů balíčků, GitHubu, NVD, OSV.dev a OpenSSF Scorecard. Naposledy aktualizováno: n/a. Strojově čitelná data (JSON).
Je Openclaw Bezpečnost Vaccine bezpečný?
Rozpis skóre důvěryhodnosti — Openclaw Bezpečnost Vaccine has a Nerq Trust Score of 56.6/100 (D). Measured across 5 independent trust signals.
Jaké je skóre důvěryhodnosti Openclaw Bezpečnost Vaccine?
Openclaw Bezpečnost Vaccine má Nerq skóre důvěryhodnosti 56.6/100 se stupněm D. Toto skóre je založeno na 5 nezávisle měřených dimenzích.
Jaká jsou klíčová bezpečnostní zjištění pro Openclaw Bezpečnost Vaccine?
Nejsilnější signál Openclaw Bezpečnost Vaccine je shoda na 94/100. Nebyly zjištěny žádné známé zranitelnosti.
Co je Openclaw Bezpečnost Vaccine a kdo jej spravuje?
| Autor | Clawman-007 |
| Kategorie | Bezpečnost |
| Zdroj | https://github.com/Clawman-007/openclaw-bezpečnost-vaccine |
Regulační shoda
| EU AI Act Risk Class | MINIMAL |
| Compliance Score | 94/100 |
| Jurisdictions | Assessed across 52 jurisdictions |
Populární alternativy v bezpečnost
What Is Openclaw Bezpečnost Vaccine?
Openclaw Bezpečnost Vaccine is a bezpečnost tool: Bezpečnost scanner for OpenClaw installations.. Nerq Trust Score: 57/100 (D).
Nerq independently analyzes every software tool, app, and extension across multiple trust signals including bezpečnost vulnerabilities, údržba activity, license shoda, and přijetí komunitou.
How Nerq Assesses Openclaw Bezpečnost Vaccine's Safety
Nerq's Trust Score is calculated from 13+ independent signals aggregated into five dimenzích. Here is how Openclaw Bezpečnost Vaccine performs in each:
- Bezpečnost (0/100): Openclaw Bezpečnost Vaccine's bezpečnost posture is poor. This score factors in known CVEs, dependency vulnerabilities, bezpečnost policy presence, and code signing practices.
- Údržba (1/100): Openclaw Bezpečnost Vaccine is potentially abandoned. We track commit frequency, release cadence, issue response times, and PR merge rates.
- Documentation (1/100): Documentation quality is insufficient. This includes README completeness, API dokumentace, usage examples, and contribution guidelines.
- Compliance (94/100): Openclaw Bezpečnost Vaccine is broadly compliant. Assessed against regulations in 52 jurisdictions including the EU AI Act, CCPA, and GDPR.
- Community (0/100): Community adoption is limited. Založeno na GitHub stars, forks, download counts, and ecosystem integrations.
The overall Trust Score of 56.6/100 (D) is the weighted combination of these measured signals. It is a measurement, not a pass/fail or suitability judgment — weigh the individual signals against your own requirements.
Who Typically Evaluates Openclaw Bezpečnost Vaccine?
Openclaw Bezpečnost Vaccine is commonly evaluated by:
- Developers and teams working with bezpečnost tools
- Organizations evaluating AI tools for their stack
- Researchers exploring AI capabilities in this domain
How to read the signals: Openclaw Bezpečnost Vaccine's measured signals (bezpečnost 0/100, údržba 1/100, dokumentace 1/100, community 0/100) are shown above. These are measurements, not a suitability judgment — weigh each signal against the requirements of your own use case and risk tolerance.
How to Verify Openclaw Bezpečnost Vaccine's Safety Yourself
While Nerq provides automated trust analysis, we recommend these additional steps before adopting any software tool:
- Check the source code — Zkontrolujte repository's bezpečnost policy, open issues, and recent commits for signs of active údržba.
- Scan dependencies — Use tools like
npm audit,pip-audit, orsnykto check for known vulnerabilities in Openclaw Bezpečnost Vaccine's dependency tree. - Recenze permissions — Understand what access Openclaw Bezpečnost Vaccine requires. Software tools should follow the principle of least privilege.
- Test in isolation — Run Openclaw Bezpečnost Vaccine in a sandboxed environment before granting access to production data or systems.
- Monitor continuously — Use Nerq's API to set up automated trust checks:
GET nerq.ai/v1/preflight?target=openclaw-bezpečnost-vaccine - Zkontrolujte license — Confirm that Openclaw Bezpečnost Vaccine's license is compatible with your intended use case. Pay attention to restrictions on commercial use, redistribution, and derivative works. Some AI tools use dual licensing or have separate terms for enterprise customers that differ from the open-source license.
- Check community signals — Look at the project's issue tracker, discussion forums, and social media presence. A healthy community actively reports bugs, contributes fixes, and discusses bezpečnost concerns openly. Low community engagement may indicate limited peer review of the codebase.
Common Safety Concerns with Openclaw Bezpečnost Vaccine
When evaluating whether Openclaw Bezpečnost Vaccine is safe, consider these category-specific risks:
Understand how Openclaw Bezpečnost Vaccine processes, stores, and transmits your data. Zkontrolujte tool's privacy policy and data retention practices, especially for sensitive or proprietary information.
Check Openclaw Bezpečnost Vaccine's dependency tree for known vulnerabilities. Tools with outdated or unmaintained dependencies pose a higher bezpečnost risk.
Regularly check for updates to Openclaw Bezpečnost Vaccine. Bezpečnost patches and bug fixes are only effective if you're running the latest version.
If Openclaw Bezpečnost Vaccine connects to external APIs or services, each integration point is a potential attack surface. Audit all third-party connections, verify that data shared with external services is minimized, and ensure that integration credentials are rotated regularly.
Verify that Openclaw Bezpečnost Vaccine's license is compatible with your intended use case. Some AI tools have restrictive licenses that limit commercial use, redistribution, or derivative works. Using Openclaw Bezpečnost Vaccine in violation of its license can expose your organization to legal liability.
Openclaw Bezpečnost Vaccine and the EU AI Act
Openclaw Bezpečnost Vaccine is classified as Minimal Risk under the EU AI Act. This is the lowest risk category, meaning it faces minimal regulatory requirements. However, transparency obligations still apply.
Nerq's shoda assessment covers 52 jurisdictions worldwide. For organizations deploying AI tools in regulated environments, understanding these classifications is essential for legal shoda.
Best Practices for Using Openclaw Bezpečnost Vaccine Safely
Whether you're an individual developer or an enterprise team, these practices will help you get the most from Openclaw Bezpečnost Vaccine while minimizing risk:
Periodically review how Openclaw Bezpečnost Vaccine is used in your workflow. Check for unexpected behavior, permissions drift, and shoda with your bezpečnost policies.
Ensure Openclaw Bezpečnost Vaccine and all its dependencies are running the latest stable versions to benefit from bezpečnost patches.
Grant Openclaw Bezpečnost Vaccine only the minimum permissions it needs to function. Avoid granting admin or root access.
Subscribe to Openclaw Bezpečnost Vaccine's bezpečnost advisories and vulnerability disclosures. Use Nerq's API to get automated trust score updates.
Create and maintain a clear policy for how Openclaw Bezpečnost Vaccine is used within your organization, including data handling guidelines and acceptable use cases.
Situations That Warrant Independent Review of Openclaw Bezpečnost Vaccine
Nerq's signals are one input. In the following situations, evaluate Openclaw Bezpečnost Vaccine's measured signals against your own requirements before making a decision:
- Environments handling sensitive or regulated data (healthcare, finance, government)
- Mission-critical systems where downtime has significant business impact
- Deployments with strict regulatory requirements that must be independently validated
For each situation, compare Openclaw Bezpečnost Vaccine's measured trust score of 56.6/100 and its individual signals against your organization's own criteria. Nerq does not assert whether Openclaw Bezpečnost Vaccine is suitable for any particular use.
How Openclaw Bezpečnost Vaccine Compares to Industry Standards
Nerq indexes over 6 million software tools, apps, and packages across dozens of categories. Among bezpečnost tools, the average Trust Score is 67/100. Openclaw Bezpečnost Vaccine's score of 56.6/100 is below the category average of 67/100.
This suggests that Openclaw Bezpečnost Vaccine trails behind many comparable bezpečnost tools. Organizations with strict bezpečnost requirements should evaluate whether higher-scoring alternatives better meet their needs.
Industry benchmarks matter because they contextualize a tool's safety profile. A score that looks střední in isolation may actually represent strong performance within a challenging category — or vice versa. Nerq's category-relative analysis helps teams make informed decisions by showing not just absolute quality, but how a tool ranks against its direct peers.
Trust Score History
Nerq continuously monitors Openclaw Bezpečnost Vaccine and recalculates its Trust Score as new data becomes available. Our scoring engine ingests real-time signals from source repositories, vulnerability databases (NVD, OSV.dev), package registries, and community metrics. When a new CVE is published, a major release ships, or údržba patterns change, Openclaw Bezpečnost Vaccine's score is updated within 24 hours.
Historical trust trends reveal whether a tool is improving, stable, or declining over time. A tool that consistently maintains or improves its score demonstrates ongoing commitment to bezpečnost and quality. Conversely, a downward trend may signal reduced údržba, growing technical debt, or unresolved vulnerabilities. To track Openclaw Bezpečnost Vaccine's score over time, use the Nerq API: GET nerq.ai/v1/preflight?target=openclaw-bezpečnost-vaccine&include=history
Nerq retains trust score snapshots at regular intervals, enabling trend analysis across weeks and months. Enterprise users can access detailed historical reports showing how each dimension — bezpečnost, údržba, dokumentace, shoda, and community — has evolved independently, providing granular visibility into which aspects of Openclaw Bezpečnost Vaccine are strengthening or weakening over time.
Openclaw Bezpečnost Vaccine vs Alternativy
In the bezpečnost category, Openclaw Bezpečnost Vaccine scores 56.6/100. There are higher-scoring alternatives available. For a detailed comparison, see:
- Openclaw Bezpečnost Vaccine vs Ciphey — Trust Score: 63.4/100
- Openclaw Bezpečnost Vaccine vs strix — Trust Score: 64.4/100
- Openclaw Bezpečnost Vaccine vs SWE-agent — Trust Score: 76.9/100
Hlavní závěry
- Openclaw Bezpečnost Vaccine has a measured Nerq Trust Score of 56.6/100 (D) — a composite of independent signals, not a suitability judgment.
- Among bezpečnost tools, Openclaw Bezpečnost Vaccine scores below the category average of 67/100 (a positional measurement relative to peers).
- The individual signals — bezpečnost, údržba, dokumentace, shoda, community — are shown above. Weigh them against your own requirements.
- Query the current measured values via Nerq's Preflight API.
Často kladené otázky
Je Openclaw Bezpečnost Vaccine bezpečný?
Jaké je skóre důvěryhodnosti Openclaw Bezpečnost Vaccine?
Jaké jsou bezpečnější alternativy k Openclaw Bezpečnost Vaccine?
Jak často se aktualizuje bezpečnostní skóre Openclaw Bezpečnost Vaccine?
Mohu používat Openclaw Bezpečnost Vaccine v regulovaném prostředí?
Viz také
Disclaimer: Skóre důvěryhodnosti Nerq jsou automatizovaná hodnocení založená na veřejně dostupných signálech. Nejsou doporučením ani zárukou. Vždy proveďte vlastní ověření.